Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-04-16
2010-10-19
Desai, Rita J (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S266000, C546S268100, C544S238000, C514S256000, C514S336000, C514S340000
Reexamination Certificate
active
07816534
ABSTRACT:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.
REFERENCES:
patent: 3277165 (1966-10-01), Schultz
patent: 4746680 (1988-05-01), Jeffery et al.
patent: 4929629 (1990-05-01), Scheinbaum
patent: 4956380 (1990-09-01), Toda et al.
patent: 4973587 (1990-11-01), Ward et al.
patent: 5013837 (1991-05-01), Ward et al.
patent: 5081122 (1992-01-01), Ward
patent: 5102667 (1992-04-01), Dubroeucq et al.
patent: 5112820 (1992-05-01), Ward
patent: 5278316 (1994-01-01), Horwell et al.
patent: 5292736 (1994-03-01), Kumar et al.
patent: 5436272 (1995-07-01), Scheinbaum
patent: 5488149 (1996-01-01), Nomoto et al.
patent: 5532237 (1996-07-01), Gallant et al.
patent: 5597797 (1997-01-01), Clark
patent: 5624941 (1997-04-01), Barth et al.
patent: 5707987 (1998-01-01), Nakagawa et al.
patent: 5795895 (1998-08-01), Anchors
patent: 5908830 (1999-06-01), Smith et al.
patent: 6011048 (2000-01-01), Mathvink et al.
patent: 6011174 (2000-01-01), Iwasawa et al.
patent: 6028084 (2000-02-01), Barth et al.
patent: 6121325 (2000-09-01), Chen et al.
patent: 6258837 (2001-07-01), Fukami et al.
patent: 6335345 (2002-01-01), Scheinbaum
patent: 6344474 (2002-02-01), Maruani et al.
patent: 6344481 (2002-02-01), Cornelius et al.
patent: 6355631 (2002-03-01), Achard et al.
patent: 6359175 (2002-03-01), Philippe et al.
patent: 6479479 (2002-11-01), Achard et al.
patent: 6509367 (2003-01-01), Martin et al.
patent: 2002/0006964 (2002-01-01), Young et al.
patent: 2002/0010192 (2002-01-01), Coe et al.
patent: 2002/0062022 (2002-05-01), Sabb et al.
patent: 2002/0091114 (2002-07-01), Piot-Grosjean et al.
patent: 2003/0114495 (2003-06-01), Finke et al.
patent: 2004/0058820 (2004-03-01), Hagmann et al.
patent: 2004/0122033 (2004-06-01), Nargund et al.
patent: 2004/0248956 (2004-12-01), Hagmann et al.
patent: 2005/0288213 (2005-12-01), MacNeil et al.
patent: 2006/0148721 (2006-07-01), Erondu
patent: 2006/0160834 (2006-07-01), Fong et al.
patent: 2006/0270650 (2006-11-01), MacNeil et al.
patent: 2007/0099884 (2007-05-01), Erondu et al.
patent: 4332738 (1995-03-01), None
patent: 0163607 (1985-05-01), None
patent: 0611749 (1994-08-01), None
patent: 0920864 (1999-06-01), None
patent: 0658546 (2001-05-01), None
patent: 1302461 (2003-04-01), None
patent: 1-156957 (1989-06-01), None
patent: 3-176469 (1991-07-01), None
patent: 08-165276 (1996-06-01), None
patent: 9-505601 (1997-03-01), None
patent: 03-220168 (2009-07-01), None
patent: 95/11880 (1995-05-01), None
patent: 95/23150 (1995-08-01), None
patent: 96/18391 (1996-06-01), None
patent: 96/33159 (1996-10-01), None
patent: 96/40912 (1996-12-01), None
patent: 97/06816 (1997-02-01), None
patent: 97/16189 (1997-05-01), None
patent: 97/17321 (1997-05-01), None
patent: 97/18833 (1997-05-01), None
patent: 97/29078 (1997-08-01), None
patent: 97/29079 (1997-08-01), None
patent: 97/46250 (1997-12-01), None
patent: 98/18481 (1998-05-01), None
patent: 98/28427 (1998-07-01), None
patent: 98/31227 (1998-07-01), None
patent: 98/32441 (1998-07-01), None
patent: 98/33765 (1998-08-01), None
patent: 98/37061 (1998-08-01), None
patent: 98/41519 (1998-09-01), None
patent: 98/43635 (1998-10-01), None
patent: 98/43636 (1998-10-01), None
patent: 98/56754 (1998-12-01), None
patent: 99/02499 (1999-01-01), None
patent: 99/31055 (1999-06-01), None
patent: 99/37667 (1999-07-01), None
patent: 00/10967 (2000-03-01), None
patent: 00/10968 (2000-03-01), None
patent: 00/37462 (2000-06-01), None
patent: 00/66578 (2000-11-01), None
patent: 00/76493 (2000-12-01), None
patent: 01/01969 (2001-01-01), None
patent: 01/09120 (2001-02-01), None
patent: 01/92229 (2001-06-01), None
patent: 01/52825 (2001-07-01), None
patent: 01/58540 (2001-08-01), None
patent: 01/58869 (2001-08-01), None
patent: 01/64632 (2001-09-01), None
patent: 01/64633 (2001-09-01), None
patent: 01/64634 (2001-09-01), None
patent: 01/70700 (2001-09-01), None
patent: 01/85092 (2001-11-01), None
patent: 01/87849 (2001-11-01), None
patent: 02/12168 (2002-02-01), None
patent: 02/19998 (2002-03-01), None
patent: 02/20488 (2002-03-01), None
patent: 02/22592 (2002-03-01), None
patent: 02/28346 (2002-04-01), None
patent: 02/32897 (2002-04-01), None
patent: 02/38551 (2002-05-01), None
patent: 02/49648 (2002-06-01), None
patent: 02/060427 (2002-08-01), None
patent: 02/060428 (2002-08-01), None
patent: 02/068388 (2002-09-01), None
patent: 02/076949 (2002-10-01), None
patent: 03/006007 (2003-01-01), None
patent: 03/007887 (2003-01-01), None
patent: 03/020217 (2003-03-01), None
patent: 03/026647 (2003-04-01), None
patent: 03/026648 (2003-04-01), None
patent: 03/027068 (2003-04-01), None
patent: 03/027069 (2003-04-01), None
patent: 03/027076 (2003-04-01), None
patent: 03/027114 (2003-04-01), None
patent: 03/037332 (2003-05-01), None
patent: 03/040107 (2003-05-01), None
patent: 03/082190 (2003-10-01), None
patent: 03/082191 (2003-10-01), None
patent: 03/086288 (2003-10-01), None
patent: 03/087037 (2003-10-01), None
patent: 2004/012671 (2004-02-01), None
patent: 2004/029204 (2004-04-01), None
patent: 2004/048317 (2004-06-01), None
patent: 2004/058145 (2004-07-01), None
patent: 2004/058741 (2004-07-01), None
patent: 2004/058744 (2004-07-01), None
patent: 2004/060870 (2004-07-01), None
patent: 2005/000809 (2005-01-01), None
patent: 2005/009479 (2005-02-01), None
patent: 2005/027837 (2005-03-01), None
patent: 2006/036770 (2006-04-01), None
patent: 2006/049933 (2006-05-01), None
Vizi, “Evidence for presynaptic cannabinoid CB1 receptor-mediated inhibition . . . ”, Eur. J. Pharmacology (2001), 237-244, vol. 431.
Batkai, “Endocannabinoids activing at vascular CB1 receptors . . . ”, Nature Medicine (2001), 827-832, vol. 7.
Schultz, “Maleamic acids that affect plasma cholesterol . . . ”, J. Med. Chem. (1967), 717-724, vol. 10.
Pines, “The stereochemistry of 2,3-diphenyl-1-methylpropylamine”, J. Med. Chem. (1967), 725-728, vol. 10.
Barth, “Cannabinoid receptor agonists and antagonists”, Exp. Opin. Therap. Patents (1998), 301-313, vol. 8.
Petitet, “The therapeutic applications of cannabinoid agonists and antagonists”, Emerging Drugs (1998), 39-53, vol. 3.
Di Marzo, “Endocannabinoids Part I: Molecular basis of endocannabinoid formation, . . . ”, Emerging Therap. Targets (2001), 241-265, vol. 5.
Grundy, “The therapeutic potential of the cannabinoids . . . ”, Exp. Opin. Investig. Drugs (2002), 1365-1374, vol. 11.
Goya, “Recent advances in cannabinoid receptor agonists and antagonists”, Exp. Opin. Ther. Patents (2000), 1529-1538, vol. 10.
Adam, “Recent advances in the cannabinoids”, Exp. Opin. Ther. Patents (2002), 1475-1489, vol. 12.
Ishiwata, “Studies on the syntheses of isoquinoine derivatives”, Yakugaku Zasshi (1951), 1272-1274, vol. 71.
Ito, “Catalytic hydrogenation of tetrahydro-4H-1,3-oxazin-4-ones . . . ”, Chem. Pharm. Bull (1972), 1762-1767, vol. 20.
D'Souza, “(R)-(+)-3-amino-2-(phenylpropanoic acid: . . . ”, J. Chem, Soc. Perkin Trans. (1995), 1-2, vol. 1.
Gutierrez-Garcia, “Enantioselective synthesis of beta-amino acids . . . ”, J. Braz. Chem. Soc. (2001), 652-660, vol. 12.
Chung, “A beta-peptide reverse turn that promotes hairpi
Armstrong Helen M.
Chang Linda L.
Guthikonda Ravindra N.
Hagmann William K.
Jewell James P.
Brown Baerbel R.
Desai Rita J
Merck Sharp & Dohme Corp.
Vidale Kenrick L.
LandOfFree
Substituted amides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted amides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191968